{"organizations": [], "uuid": "a44308828e67c8233d0ef08c1bba2a9d9e7159f7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-aveo-pharmaceuticals-entered-into/brief-aveo-pharmaceuticals-entered-into-sales-agreement-with-leerink-partners-idUSFWN1Q61DE", "country": "US", "domain_rank": 408, "title": "BRIEF-Aveo Pharmaceuticals ‍Entered Into Sales Agreement With Leerink Partners", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-16T23:13:00.000+02:00", "replies_count": 0, "uuid": "a44308828e67c8233d0ef08c1bba2a9d9e7159f7"}, "author": "", "url": "https://www.reuters.com/article/brief-aveo-pharmaceuticals-entered-into/brief-aveo-pharmaceuticals-entered-into-sales-agreement-with-leerink-partners-idUSFWN1Q61DE", "ord_in_thread": 0, "title": "BRIEF-Aveo Pharmaceuticals ‍Entered Into Sales Agreement With Leerink Partners", "locations": [], "entities": {"persons": [{"name": "leerin", "sentiment": "negative"}, {"name": "leerink", "sentiment": "none"}], "locations": [], "organizations": [{"name": "leerink partners", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "aveo pharmaceuticals inc", "sentiment": "none"}, {"name": "partners reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 16 PM / Updated 11 minutes ago BRIEF-Aveo Pharmaceuticals ‍Entered Into Sales Agreement With Leerink Partners Reuters Staff Feb 16 (Reuters) - Aveo Pharmaceuticals Inc: * AVEO PHARMACEUTICALS SAYS ‍ENTERED INTO A SALES AGREEMENT WITH LEERINK PARTNERS - SEC FILING * AVEO PHARMACEUTICALS - ‍PURSUANT TO AGREEMENT, CO MAY ISSUE, SELL SHARES OF COMMON STOCK, $0.001 PAR VALUE PER SHARE FROM TIME TO TIME THROUGH LEERINK​ Source text: ( bit.ly/2oaeRKo )  ", "external_links": [], "published": "2018-02-16T23:13:00.000+02:00", "crawled": "2018-02-16T23:35:41.029+02:00", "highlightTitle": ""}